Becton Dickinson (NYSE:BDX) yesterday announced a new point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19 in as little as 15 minutes. The new test, developed and manufactured by BioMedomics (Morrisville, N.C.), will be available through BD and distributed exclusively by Henry Schein (NSDQ:HSIC) to healthcare providers throughout the […]
Homeland Security warns on BD Pyxis Medstation and Pyxis Anesthesia
The U.S. Dept. of Homeland Security (DHS) issued a medical advisory warning for a potential software vulnerability in the Pyxis MedStation and Pyxis Anesthesia (PAS) ES system made by Becton Dickinson (NYSE:BDX). According to the DHS warning, Becton Dickinson reported the vulnerability to the Cybersecurity and Infrastructure Security Agency (CISA). Affected models of the drug-dispensing devices […]
5 companies on the front lines of the coronavirus fight
Nancy Crotti, Managing Editor and Danielle Kirsh, Senior Editor Amid the stock market roller-coaster ride that began last month, medtech companies that make devices and diagnostic tests vital to fighting COVID-19 may ultimately fare better than others, but it’s hard to tell until the virus peaks and people get back to work. At midafternoon today, […]
How will coronavirus affect medtech companies that rely on elective surgeries?
One thing is likely to hurt some medtech companies more than others during the coronavirus pandemic: an elective surgical procedure slowdown. This thought had begun to emerge last week among industry watchers, but a pair of tweets over the weekend gained thousands of “likes” and retweets. The American College of Surgeons called for hospitals to […]
COVID-19 test development surges with pandemic
Companies around the world are racing to develop and distribute tests for COVID-19 to laboratories and to market other products and services they say can help patients and healthcare providers cope with the pandemic. On March 13, the FDA gave Thermo Fisher Scientific (NYSE:TMO) emergency use authorization (EUA) for a diagnostic test that certain U.S. laboratories […]
BD recalls hundreds of thousands of Alaris pumps due to multiple issues
The FDA today warned on a Class I recall of Becton Dickinson (NYSE:BDX) Alaris system infusion pumps due to multiple system errors, software errors, and use-related errors. All lots of five different models of the Alaris system were included in the recall that Becton Dickinson initiated on Feb. 4. In total, the company recalled 774,000 devices […]
BD warns on some ambulatory syringe pumps
Becton Dickinson (NYSE:BDX) issued a field safety notice in the United Kingdom to warn on an issue with its T34 and T34L (T60) ambulatory syringe pumps. The company was alerted to an issue with the syringe pumps that could cause risk of under-infusion and/or alarm failure, according to the notice published today. Get the full story at our […]
BD touts cybersecurity cred of its microbiology informatics software
Becton Dickinson (NYSE:BDX) announced that its BD Synapsys microbiology informatics solution received certification from the Underwriters Laboratory Cybersecurity Assurance Program (UL CAP). UL CAP is an independent program that uses standardized, testable criteria to assess software vulnerabilities and weaknesses. BD touts its BD Synapsys software as one of the first life-science diagnostics informatics platforms to meet […]
BD warns on some Alaris extension sets
Becton Dickinson (NYSE:BDX) issued an urgent field safety notice to warn customers in Europe of an issue with specific lots of its Alaris extension sets. Through customer feedback, the company found the potential for the male luer of the Alaris extension set to become disconnected from the female luer of the connecting device, both upon initial […]
How medtech companies are responding to the deadly coronavirus outbreak
Medical device companies all over have felt the impact of the coronavirus pandemic that originated in China. The latest figures from the World Health Organization (WHO) show that at least 600 people have died — almost all of them in China — with tens of thousands of confirmed coronavirus cases in dozens of countries. Demand […]
BD plummets on Q1 results as it cuts 2020 outlook
Becton Dickinson (NYSE:BDX) shares are down more than 10% today after the medtech giant lowered its guidance for the year amid ongoing problems with its Alaris infusion pump. The Franklin Lakes, N.J.-based company posted profits of $240 million, or 87¢ per share, on sales of $4.23 billion for the three months ended Dec. 31, 2019, for […]
- 1
- 2
- 3
- …
- 34
- Next Page »
